These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38396558)

  • 21. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
    Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
    Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of imprecise sampling time for 10- and 30-min thyrotropin-releasing hormone stimulation tests in horses.
    Vorster DM; Wang W; Kemp KL; Bamford NJ; Bertin FR
    Equine Vet J; 2024 Mar; 56(2):291-298. PubMed ID: 37649416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
    de Laat MA; Sillence MN; Reiche DB
    J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of blue light therapy on plasma adrenocorticotropic hormone (ACTH) and hypertrichosis in horses with pituitary pars intermedia dysfunction.
    Miller AB; Murphy BA; Adams AA
    Domest Anim Endocrinol; 2022 Jan; 78():106651. PubMed ID: 34656964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
    Tadros EM; Fowlie JG; Refsal KR; Marteniuk J; Schott HC
    Equine Vet J; 2019 Jan; 51(1):52-56. PubMed ID: 29761574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic orientation values for ACTH and other parameters for clinically healthy donkeys and mules (insulin, triglycerides, glucose, fructosamines, and ɣ-GT).
    Gehlen H; Twickel S; Stöckle S; Weber C; Bartmann CP
    J Anim Physiol Anim Nutr (Berl); 2020 Mar; 104(2):679-689. PubMed ID: 31900994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.
    Fortin JS; Benskey MJ; Lookingland KJ; Patterson JS; Howey EB; Goudreau JL; Schott HC
    BMC Vet Res; 2020 Sep; 16(1):356. PubMed ID: 32977825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
    Knowles EJ; Menzies-Gow NJ; Mair TS
    Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy.
    Banse HE; Whitehead AE; McFarlane D; Chelikani PK
    Domest Anim Endocrinol; 2021 Jul; 76():106620. PubMed ID: 33740552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.
    Hodge E; Kowalski A; Torcivia C; Lindborg S; Stefanovski D; Hart K; Frank N; van Eps A
    J Vet Intern Med; 2019 Sep; 33(5):2272-2279. PubMed ID: 31432575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine Disorders of the Equine Athlete.
    Frank N
    Vet Clin North Am Equine Pract; 2018 Aug; 34(2):299-312. PubMed ID: 29857965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic properties of pergolide mesylate following single and multiple-dose administration in donkeys (Equus asinus).
    Xue C; Davis J; Berghaus LJ; Hanafi A; Vaughn SA; Hart KA
    Equine Vet J; 2023 Nov; 55(6):1078-1085. PubMed ID: 36572900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses.
    Zak A; Siwinska N; Elzinga S; Barker VD; Stefaniak T; Schanbacher BJ; Place NJ; Niedzwiedz A; Adams AA
    Domest Anim Endocrinol; 2020 Jul; 72():106476. PubMed ID: 32380311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses.
    McGowan TW; Pinchbeck GP; McGowan CM
    Equine Vet J; 2013 Jan; 45(1):74-9. PubMed ID: 22594955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-sectional study to identify the prevalence of and factors associated with laminitis in UK donkeys.
    Menzies-Gow NJ; Wakeel F; Little H; Buil J; Rickards K
    Equine Vet J; 2021 Sep; ():. PubMed ID: 34478179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological investigation of insulin dysregulation in Shetland and Welsh ponies in Australia.
    Clark BL; Norton EM; Bamford NJ; Randhawa IAS; Kemp KL; McCue ME; Bertin FR; Stewart AJ
    Equine Vet J; 2024 Mar; 56(2):281-290. PubMed ID: 38173146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.
    Rendle DI; Duz M; Beech J; Parkin T; Durham AE
    J Vet Intern Med; 2015 Jan; 29(1):355-61. PubMed ID: 25312676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin dysregulation.
    Frank N; Tadros EM
    Equine Vet J; 2014 Jan; 46(1):103-12. PubMed ID: 24033478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
    McFarlane D; Beech J; Cribb A
    Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.